BioCryst Reports Fourth Quarter and Full Year 2016 Financial Results
Go back to BioCryst Reports Fourth Quarter and Full Year 2016 Financial Results| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.69 +0.03 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.66 | 52 Week High | $10.98 | |||
| Open | $9.72 | 52 Week Low | $1.63 | |||
| Day High | $9.91 | P/E | N/A | |||
| Day Low | $9.65 | EPS | $-0.68 | |||
| Volume | 608,633 | |||||

